Epithelial-to-mesenchymal transition (EMT) is usually a crucial step in the early stage of cancer metastasis, characterized by downregulation of the epithelial marker E-cadherin and upregulation of the mesenchymal marker N-cadherin [22]. This evidence concerns the gene CDH2 and cancer.